Business1 outlet
AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal
AbbVie is planning to raise at least $8 billion through an investment-grade bond offering to partially finance its acquisition of Apogee Therapeutics. This debt financing strategy allows the pharmaceutical company to fund a significant portion of the deal while maintaining its investment-grade credit rating.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
How does this lean?
Comments
0No comments yet. Say what you noticed in the coverage.
Trending